| Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsules Under Fasting Conditions (NCT01045642) | Dr. Reddy's Laboratories Limited | 2006-12-01 |
| Ursodiol Tablets 500 mg Under Fasting Conditions (NCT00909610) | Teva Pharmaceuticals USA | 2006-12-01 |
| VivaGel™ in Healthy Young Women (NCT00331032) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-12-01 |
| Rituxan With or Without Methotrexate in Psoriatic Arthritis (NCT00509678) | Swedish Medical Center | 2006-12-01 |
| Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer (NCT00448149) | The Methodist Hospital Research Institute | 2006-12-01 |
| A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease. (NCT00531804) | Hoffmann-La Roche | 2006-12-01 |
| Pilot, Proof-of-Concept Study of Sublingual Tizanidine in Children With Chronic Traumatic Brain Injury (TBI) (NCT00287157) | Teva GTC | 2006-12-01 |
| Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 mg Under Fasting Conditions (NCT01055938) | Dr. Reddy's Laboratories Limited | 2006-12-01 |
| Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer (NCT00443573) | ARCA Biopharma, Inc. | 2006-12-01 |
| Use of Hair to Diagnose the Presence of Breast Cancer (NCT00419900) | Fermiscan Ltd | 2006-12-01 |
| The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM) (NCT01449019) | Ludwig-Maximilians - University of Munich | 2006-12-01 |
| Open Label, Phase I ZD6474 Head and Neck Cancer Study (NCT00450138) | Sanofi | 2006-12-01 |
| Phase I/II Clinical Trial Combining hTERT Tumor Vaccine & Autologous T Cells in Patients With Advanced Myeloma (NCT00834665) | University of Pennsylvania | 2006-12-01 |
| Transcranial Ultrasound in Clinical SONothrombolysis (NCT00504842) | ImaRx Therapeutics | 2006-12-01 |
| A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies (NCT01080664) | EMD Serono | 2006-12-01 |
| Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors (NCT00493883) | Southwestern Regional Medical Center | 2006-12-01 |
| IMRT Tomotherapy for Esophagus Cancer (NCT00593723) | Washington University School of Medicine | 2006-12-01 |
| Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis (NCT00406237) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-12-01 |
| Dose Escalation Study to Evaluate Oral Rotavirus Vaccine 116E Live Attenuated in Healthy Infants 8 to 20 Weeks Old (NCT00439660) | Bharat Biotech International Limited | 2006-12-01 |
| Food Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg (NCT00650403) | Mylan Pharmaceuticals Inc | 2006-12-01 |
| Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions (NCT01340625) | Teva Pharmaceuticals USA | 2006-12-01 |
| Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects (NCT01964573) | UCB Pharma | 2006-12-01 |
| Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) (NCT00410566) | Genzyme, a Sanofi Company | 2006-12-01 |
| New Type of a Pancreaticojejunostomy (NCT00471627) | Tampere University | 2006-12-01 |
| A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System (NCT00614029) | Zogenix, Inc. | 2006-12-01 |
| Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy (NCT00424151) | Silkiss, Rona Z., M.D., FACS | 2006-12-01 |
| Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer (NCT00401401) | Genmab | 2006-12-01 |
| Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart (NCT00411073) | GlaxoSmithKline | 2006-12-01 |
| Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants (NCT00722839) | City of Hope Medical Center | 2006-12-01 |
| Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma (NCT00438984) | Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium | 2006-12-01 |
| Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of Folate (NCT01258660) | Bayer | 2006-12-01 |
| Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children (NCT00312091) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-12-01 |
| Study Evaluating SCA-136 Tolerability With Dose Titration and Food (NCT00420706) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-12-01 |
| A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors (NCT01358227) | Proacta, Incorporated | 2006-12-01 |
| A Pharmacokinetic (PK) Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of Age (NCT00410709) | ParaPRO LLC | 2006-12-01 |
| Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity (NCT00358293) | Teva GTC | 2006-12-01 |
| Youth Substance Use Prevention/Reduction Through Science-based Drug Abuse Education (NCT00612482) | Boston Children's Hospital | 2006-12-01 |
| Safety and Acceptability Study of the UC-781 Microbicide Gel Applied Rectally (NCT00408538) | University of California, Los Angeles | 2006-12-01 |
| Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis (NCT00440492) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-12-01 |
| Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma (NCT00415064) | AEterna Zentaris | 2006-12-01 |
| Photodynamic and Pharmacologic Treatment of CNV (NCT00570193) | Mid-Atlantic Retina Consultations, Inc. | 2006-12-01 |
| Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer (NCT00392821) | SCRI Development Innovations, LLC | 2006-12-01 |
| EMD 521873 in Advanced Solid Tumors, MTD Finding (NCT01032681) | Merck KGaA, Darmstadt, Germany | 2006-12-01 |
| Surgical Sympathetic Blockade in Heart Failure (NCT01224899) | University of Sao Paulo | 2006-12-01 |
| An Investigation To Determine The Potential Interaction Effect Between GW876008 And Midazolam. (NCT00423761) | GlaxoSmithKline | 2006-12-01 |
| Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS) (NCT00399451) | Liaoyang Central Hospital | 2006-12-01 |
| Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides (NCT00445419) | Pevion Biotech Ltd | 2006-12-01 |
| Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (NCT00420615) | Novartis Pharmaceuticals | 2006-12-01 |
| Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers (NCT00432770) | Archemix Corp. | 2006-12-01 |
| Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer (NCT00414388) | Oncology Specialists, S.C. | 2006-12-01 |
| Study of the Safety, Tolerability, Pharmacokinetics and Pharmcodynamics of ILV-094 in Healthy Subjects (NCT00447681) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-12-01 |
| A Safety Study of EPC2407, A Anti-Cancer Drug With Vascular Disrupting Activity: In Patients With Advanced Cancer (NCT00423410) | EpiCept Corporation | 2006-12-01 |
| Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00415324) | National Cancer Institute (NCI) | 2006-12-01 |
| Osteopathic Manipulative Treatment for Post-Operative Nausea and Vomiting (NCT00387361) | University of North Texas Health Science Center | 2006-12-01 |
| Sirolimus for Autoimmune Disease of Blood Cells (NCT00392951) | Children's Hospital of Philadelphia | 2006-12-01 |
| Drug Interaction - Oral Contraceptive (NCT00399685) | Bristol-Myers Squibb | 2006-12-01 |
| Thymoglobulin (ATG) Dose Finding Study (NCT00409695) | M.D. Anderson Cancer Center | 2006-12-01 |
| Bioavailability of 2 Different Nevirapine Extended Release Formulations Compared to Viramune® in HIV-1 Infected Subjects (NCT02194179) | Boehringer Ingelheim | 2006-12-01 |
| Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas (NCT00766753) | Frank Lieberman | 2006-12-01 |
| Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available (NCT00768391) | Eli Lilly and Company | 2006-12-01 |
| Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditions (NCT01045434) | Dr. Reddy's Laboratories Limited | 2006-12-01 |
| Study Of SU011248 In Combination With Docetaxel And Trastuzumab In Patients With Advanced Breast Cancer HER-2 Positive (NCT00372424) | Pfizer | 2006-12-01 |
| Treatment With MK6592 and an Anti-cancer Drug in Patients With Advanced Solid Tumors (6592-001) (NCT00359671) | Merck Sharp & Dohme LLC | 2006-12-01 |
| Study of Anginera in Adults With a Left Ventricular Assist Device (LVAD) as Bridge to Transplant (NCT00364598) | Theregen, Inc. | 2006-12-01 |
| Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3 (NCT00136786) | New York State Psychiatric Institute | 2006-12-01 |
| A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia (NCT00419250) | Celgene | 2006-12-01 |
| Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia (NCT00401739) | CSL Limited | 2006-12-01 |
| Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer (NCT00405405) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2006-12-01 |
| Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT00467194) | National Cancer Centre, Singapore | 2006-12-01 |
| Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases (NCT00437957) | H. Lee Moffitt Cancer Center and Research Institute | 2006-12-01 |
| Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma (NCT00972712) | Emory University | 2006-12-01 |
| Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox. (NCT00432627) | Novartis Pharmaceuticals | 2006-12-01 |
| Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma (NCT00450814) | Mayo Clinic | 2006-11-30 |
| PET Whole Body Imaging Using a Peripheral Benzodiazepine Receptor Ligand [C-11]PBR28 (NCT00407693) | National Institute of Mental Health (NIMH) | 2006-11-28 |
| Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma (NCT00445341) | National Cancer Institute (NCI) | 2006-11-27 |
| Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia (NCT00392353) | National Cancer Institute (NCI) | 2006-11-22 |
| Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease (NCT00423514) | Memorial Sloan Kettering Cancer Center | 2006-11-20 |
| Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery (NCT00410553) | National Cancer Institute (NCI) | 2006-11-14 |
| A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant). (NCT00405080) | GlaxoSmithKline | 2006-11-11 |
| Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma (NCT00418496) | Ohio State University Comprehensive Cancer Center | 2006-11-08 |
| A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors. (NCT00676910) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2006-11-01 |
| Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies (NCT00430846) | Seagen Inc. | 2006-11-01 |
| Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition (NCT01503450) | Dr. Reddy's Laboratories Limited | 2006-11-01 |
| Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects. (NCT00416728) | Novartis | 2006-11-01 |
| Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib (NCT00441155) | Novartis Pharmaceuticals | 2006-11-01 |
| Safety of and Immune Response to a DNA HIV Vaccine Followed by an Adenoviral Vaccine Boost Given Three Different Ways to HIV Uninfected Adults (NCT00384787) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-11-01 |
| Physical Activities in Daily Life After Lung Transplantation (NCT00395889) | KU Leuven | 2006-11-01 |
| Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer (NCT00406276) | Emory University | 2006-11-01 |
| Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans (NCT00393445) | Ludwig-Maximilians - University of Munich | 2006-11-01 |
| Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC) (NCT00411593) | M.D. Anderson Cancer Center | 2006-11-01 |
| Driving Neuroplasticity With Nerve Stimulation and Modified CIT (NCT02587234) | University of Kentucky | 2006-11-01 |
| Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer (NCT00402025) | BioVex Limited | 2006-11-01 |
| A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers (NCT00392080) | Pfizer | 2006-11-01 |
| The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIV (NCT00395720) | University of Oxford | 2006-11-01 |
| Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects (NCT00448032) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-11-01 |
| Mg Induced Changes From Day 0 to Day 28 on Serum and Urine Bone Metabolic Parameters in 70 y Old Females (no 50). (NCT02549521) | Oslo University Hospital | 2006-11-01 |
| Study of Immunotoxin, MR1-1 (NCT01009866) | Darell D. Bigner, MD, PhD | 2006-11-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 11634 Solution in Healthy Male Volunteers (NCT02214914) | Boehringer Ingelheim | 2006-11-01 |
| Phase I Trial of Silymarin for Chronic Liver Diseases (NCT00389376) | National Center for Complementary and Integrative Health (NCCIH) | 2006-11-01 |
| A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers (NCT00404274) | GlaxoSmithKline | 2006-11-01 |